Algorithm for the diagnosis and management of the multisystem inflammatory syndrome in children associated with COVID-19.
Serhat EmeksizBanu Çelikel AcarAyşe Esin KibarAslınur Özkaya ParlakayOktay PerkGülsüm İclal BayhanGüzin CinelNamık ÖzbekMüjdem Nur AzılıElif ÇelikelHalise AkçaEmine Dibek MısırlıoğluUmut Selda Bayrakçıİbrahim İlker ÇetinAyşegül Neşe Çıtak KurtMehmet BoyrazŞamil HızlıEmrah ŞenelPublished in: International journal of clinical practice (2021)
Children may experience acute cardiac decompensation or other organ system failure due to this severe inflammatory condition. Therefore, patients with severe symptoms of MIS-C should be managed in a paediatric intensive care setting, as rapid clinical deterioration may occur. Therapeutic approaches for MIS-C should be tailored depending on the patients' phenotypes. Plasmapheresis may be useful as a standard treatment to control hypercytokinemia in cases of MIS-C with severe symptoms. Long-term follow-up of patients with cardiac involvement is required to identify any sequelae of MIS-C.
Keyphrases
- early onset
- end stage renal disease
- young adults
- drug induced
- left ventricular
- coronavirus disease
- oxidative stress
- chronic kidney disease
- sars cov
- ejection fraction
- newly diagnosed
- emergency department
- machine learning
- deep learning
- peritoneal dialysis
- case report
- heart failure
- sleep quality
- depressive symptoms
- patient reported outcomes
- hepatitis b virus
- aortic dissection
- neural network